methyl mannoside, (alpha-d)-isomer has been researched along with methyl alpha-d-galactopyranoside in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Abderrahmen, C; Boukerb, AM; Cecioni, S; Cournoyer, B; Darblade, B; de Bentzmann, S; Dessein, R; Faure, K; Galanos, N; Gillon, E; Grandjean, T; Guéry, B; Havet, S; Imberty, A; Kipnis, E; Matthews, SE; Méar, JB; Redelberger, D; Rousset, A; Thépaut, M; Vidal, S | 1 |
Hauck, D; Meiers, J; Röhrig, T; Titz, A; Wagner, S; Zahorska, E | 1 |
Kulkarni, SS; Singh, K | 1 |
Meiers, J; Rox, K; Titz, A | 1 |
1 review(s) available for methyl mannoside, (alpha-d)-isomer and methyl alpha-d-galactopyranoside
Article | Year |
---|---|
Small Carbohydrate Derivatives as Potent Antibiofilm Agents.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Carbohydrates; Virulence | 2022 |
3 other study(ies) available for methyl mannoside, (alpha-d)-isomer and methyl alpha-d-galactopyranoside
Article | Year |
---|---|
Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection.
Topics: Adhesins, Bacterial; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calixarenes; Cells, Cultured; Fluorescent Antibody Technique; Glycosylation; Humans; Lectins; Lung; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Models, Chemical; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2014 |
Directing Drugs to Bugs: Antibiotic-Carbohydrate Conjugates Targeting Biofilm-Associated Lectins of
Topics: Anti-Bacterial Agents; Biofilms; Carbohydrates; Cell Line, Tumor; Ciprofloxacin; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Lectins; Molecular Structure; Pseudomonas aeruginosa; Structure-Activity Relationship | 2020 |
Lectin-Targeted Prodrugs Activated by
Topics: Anti-Bacterial Agents; Biofilms; Fluoroquinolones; Humans; Lectins; Prodrugs; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2022 |